THE CCDC55 COUPLES CANNABINOID RECEPTOR CNR1 TO A PUTATIVE DISC1 SCHIZOPHRENIA PATHWAY

被引:6
|
作者
Xie, J. [1 ,2 ]
Gizatullin, R. [1 ,2 ]
Vukojevic, V. [2 ]
Leopardi, R. [1 ,2 ]
机构
[1] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden
[2] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
关键词
coiled coil domain-containing 55; cannabinoid receptor 1; disrupted-in-schizophrenia; 1; cannabinoid receptor interacting protein 1a; Ran binding protein 9; schizophrenia; SUSCEPTIBILITY LOCUS; GENETIC ASSOCIATION; SCAFFOLDING PROTEIN; SWEDISH CONSCRIPTS; NEURITE OUTGROWTH; RANBPM; PSYCHOSIS; BRAIN; DISRUPTED-IN-SCHIZOPHRENIA-1; POLYMORPHISM;
D O I
10.1016/j.neuroscience.2015.10.012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Purpose: Our previous study suggested that the coiled coil domain-containing 55 gene (CCDC55), also named as NSRP1 (nuclear speckle splicing regulatory protein 1 (NSRP1)), was encompassed in a haplotype block spanning over the serotonin transporter (5-HTT) gene in patients with schizophrenia (SCZ). However, the neurobiological function of CCDC55 gene remains unknown. This study aims to uncover the potential role of CCDC55 in SCZ-associated molecular pathways. Experimental design: Using molecular cloning, sequencing and immune blotting to identify basic properties, yeast two-hybrid screening and glutathione S-transferase (GST) pull-down assay to test protein-protein interaction, and confocal laser scanning microscopy (CSLM) to show intracellular interaction of proteins. Principal findings: (i) CCDC55 is expressed as a nuclear protein in human neuronal cells; (ii) Protein-protein interaction analyses showed CCDC55 physically interacted with Ran binding protein 9 (RanBP9) and disrupted in schizophrenia 1 (DISC1); (iii) CCDC55 and RanBP9 co-localized in the nucleus of human neuronal cells; (iv) CCDC55 also interacted with the cannabinoid receptor 1 (CNR1), and with the brain cannabinoid receptor-interacting protein 1a (CNRIP1a); (v) CNR1 activation in differentiated human neuronal cells resulted in an altered RanBP9 localization. Conclusion: CCDC55 may be involved in a functional bridging between the CNR1 activation and the DISC1/RanBP9-associated pathways. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:723 / 730
页数:8
相关论文
共 38 条
  • [1] Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia
    Tsai, SJ
    Wang, YC
    Hong, CJ
    PSYCHIATRIC GENETICS, 2000, 10 (03) : 149 - 151
  • [2] CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia
    H Ujike
    M Takaki
    K Nakata
    Y Tanaka
    T Takeda
    M Kodama
    Y Fujiwara
    A Sakai
    S Kuroda
    Molecular Psychiatry, 2002, 7 : 515 - 518
  • [3] CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia
    Ujike, H
    Takaki, M
    Nakata, K
    Tanaka, Y
    Takeda, T
    Kodama, M
    Fujiwara, Y
    Sakai, A
    Kuroda, S
    MOLECULAR PSYCHIATRY, 2002, 7 (05) : 515 - 518
  • [4] (AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population
    Isabel Martínez-Gras
    Janet Hoenicka
    Guillermo Ponce
    Roberto Rodríguez–Jiménez
    Miguel Angel Jiménez-Arriero
    Elena Pérez-Hernandez
    Israel Ampuero
    Jose Antonio Ramos-Atance
    Tomas Palomo
    Gabriel Rubio
    European Archives of Psychiatry and Clinical Neuroscience, 2006, 256 : 437 - 441
  • [5] (AAT)n repeat in the cannabinoid receptor gene, CNR1:: association with schizophrenia in a Spanish population
    Martinez-Gras, Isabel
    Hoenicka, Janet
    Ponce, Guillermo
    Rodriguez-Jimenez, Roberto
    Angel Jimenez-Arriero, Miguel
    Perez-Hernandez, Elena
    Ampuero, Israel
    Antonio Ramos-Atance, Jose
    Palomo, Tomas
    Rubio, Gabriel
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2006, 256 (07) : 437 - 441
  • [6] Association study of Cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia
    Tiwari, A. K.
    Zai, C. C.
    Likhodi, O.
    Voineskos, A. N.
    Meltzer, H. Y.
    Lieberman, J. A.
    Potkin, S. G.
    Remington, G.
    Mueller, D. J.
    Kennedy, J. L.
    PHARMACOGENOMICS JOURNAL, 2012, 12 (03) : 260 - 266
  • [7] Association study of Cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia
    A K Tiwari
    C C Zai
    O Likhodi
    A N Voineskos
    H Y Meltzer
    J A Lieberman
    S G Potkin
    G Remington
    D J Müller
    J L Kennedy
    The Pharmacogenomics Journal, 2012, 12 : 260 - 266
  • [8] Cannabinoid Receptor 1 (CNR1) Gene Polymorphisms in Schizophrenia Patients: Rs6454674 Polymorphism is Associated with Disease Severity
    Copoglu, Umit Sertan
    Igci, Mehri
    Bozgeyik, Esra
    Kokacya, Mehmet Hanifi
    Igci, Yusuf Ziya
    Ozden, Aslan
    Bulbul, Feridun
    Alpak, Gokay
    Ari, Mustafa
    Savas, Haluk Asuman
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 25 (04): : 341 - 347
  • [9] Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1
    Proudnikov, D.
    Kroslak, T.
    Sipe, J. C.
    Randesi, M.
    Li, D.
    Hamon, S.
    Ho, A.
    Ott, J.
    Kreek, M. J.
    PHARMACOGENOMICS JOURNAL, 2010, 10 (03) : 232 - 242
  • [10] Tourette syndrome is not caused by mutations in the central cannabinoid receptor (CNR1) gene
    Gadzicki, D
    Müller-Vahl, KR
    Heller, D
    Ossege, S
    Nöthen, MM
    Hebebrand, J
    Stuhrmann, M
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2004, 127B (01) : 97 - 103